Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AGRX
일자시간출처헤드라인심볼기업
2019/07/0905:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/07/0905:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/07/0119:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/06/2821:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/06/2505:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/06/2505:15GlobeNewswire Inc.Agile Therapeutics Announces FDA Advisory Committee Meeting for its Investigational Transdermal Low-Dose Contraceptive Patch,...NASDAQ:AGRXAgile Therapeutics Inc
2019/06/1205:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/06/0805:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/06/0805:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/06/0805:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/06/0805:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/06/0805:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/06/0805:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/06/0705:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/05/2305:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/05/2220:00GlobeNewswire Inc.Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®NASDAQ:AGRXAgile Therapeutics Inc
2019/05/1720:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/05/1720:30GlobeNewswire Inc.Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla®NASDAQ:AGRXAgile Therapeutics Inc
2019/05/0921:00GlobeNewswire Inc.Agile Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare ConferenceNASDAQ:AGRXAgile Therapeutics Inc
2019/05/0705:30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/05/0405:36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AGRXAgile Therapeutics Inc
2019/05/0321:00GlobeNewswire Inc.Agile Therapeutics to Present Combined Safety Data from Three Phase 3 Studies at the 2019 ACOG Annual MeetingNASDAQ:AGRXAgile Therapeutics Inc
2019/05/0305:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
2019/05/0305:15GlobeNewswire Inc.Agile Therapeutics Reports First Quarter 2019 Financial ResultsNASDAQ:AGRXAgile Therapeutics Inc
2019/04/2606:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AGRXAgile Therapeutics Inc
2019/04/0206:05Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:AGRXAgile Therapeutics Inc
2019/04/0206:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/03/2821:00GlobeNewswire Inc.Agile Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference in London, UKNASDAQ:AGRXAgile Therapeutics Inc
2019/03/2706:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGRXAgile Therapeutics Inc
2019/03/2006:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
 검색 관련기사 보기:NASDAQ:AGRX